NCT07179471Recruiting
Fake Carbs Practice With AID System - MiniMed 780G in Children and Adolescents With T1D.
"Fake Carbs" Practice in the Glycemic Outcomes in Children and Adolescents Using AID System: A Cross-over Observational Study
Source: ClinicalTrials.gov · Last updated 17 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Hybrid Closed Loop (HCL) systems, such as the MiniMed 780G, have significantly improved glycemic outcomes in Type 1 Diabetes (T1D) management. The MiniMed 780G, an Advanced Hybrid Closed Loop (AHCL) system, features autocorrection boluses and unique insulin adjustment technologies. While effective, the system requires user input for meal announcements. Some individuals attempt to "trick" the system by entering "fake carbs" to prompt additional insulin corrections. However, clinical evidence suggests this practice does not improve glycemic outcomes. This study, conducted in Athens, Greece, will involve 40 children and adolescents (ages 7-18) with Type 1 Diabetes who have been using the MiniMed 780G system for over 6 months. The open-label, crossover design explores the impact of 'fake carbohydrates' on glycemic control. Participants will be split into two groups: one starts with 'fake carbohydrates' and then stops, while the other does the reverse. Over two weeks, their glycemic outcomes will be monitored and compared, with exclusions for severe diabetes complications or serious diabetic events This study hypothesizes that using "fake carbs" does not enhance glycemic control. Findings are expected to provide evidence-based insights to optimize diabetes management and improve clinical guidance for HCL system users.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 40 (estimated)
- First submitted
- 3 Jul 2025
- Start date
- 4 Jun 2025
- Primary completion date
- 30 Dec 2025
- Lead sponsor
- Maria Chatzipsalti
- Diseases
- Type 1 diabetes
- NCT number
- NCT07179471
What you commit to
- Study type: Observational
- Planned participants: 40
- From 4 Jun 2025 to the primary completion date, 30 Dec 2025
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Participants with significant diabetes complications
Other
- Participants with severe episode of diabetic ketoacidosis in the last 6 months
- Participants with hypoglycemia in the last 6 months.
Who the study is looking for
- Participants aged 7-18 years
- T1D \>6 months
- on MiniMed 780G system in automode.
Age in the registry: 7 years to 19 years · Sex: All · Does not accept healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Diabetes Center Coordinator of this site? Confirm its status | Athens | Greece | Recruiting |
| Athens General Children's Hospital "Pan. & Aglaia Kyriakou" Coordinator of this site? Confirm its status | Athens | Greece | Active, not recruiting |
| Athens, Attiki Coordinator of this site? Confirm its status | Athens | Greece | Active, not recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.